The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Mutual repression between steroid and xenobiotic receptor and NF- B signaling pathways links xenobiotic metabolism and inflammation
Open accessAbstract
While it has long been known that inflammation and infection reduce expression of hepatic cytochrome P450 (CYP) genes involved in xenobiotic metabolism and that exposure to xenobiotic chemicals can impair immune function, the molecular mechanisms underlying both of these phenomena have remained largely unknown. Here we show that activation of the nuclear steroid and xenobiotic receptor (SXR) by commonly used drugs in humans inhibits the activity of NF-kappaB, a key regulator of inflammation and the immune response. NF-kappaB target genes are upregulated and small bowel inflammation is significantly increased in mice lacking the SXR ortholog pregnane X receptor (PXR), thereby demonstrating a direct link between SXR and drug-mediated antagonism of NF-kappaB. Interestingly, NF-kappaB activation reciprocally inhibits SXR and its target genes whereas inhibition of NF-kappaB enhances SXR activity. This SXR/PXR-NF-kappaB axis provides a molecular explanation for the suppression of hepatic CYP mRNAs by inflammatory stimuli as well as the immunosuppressant effects of xenobiotics and SXR-responsive drugs. This mechanistic relationship has clinical consequences for individuals undergoing therapeutic exposure to the wide variety of drugs that are also SXR agonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Tuberculosis: Commentary on a Reemergent Killer
Bloom, B. R., & Murray, C. J. L. (1992) · Science · doi:10.1126/science.257.5073.1055 · Cited by 1,373
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
Guengerich, F. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.1 · Cited by 1,267
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158
Immunity, Inflammation, and Allergy in the Gut
MacDonald, T. T., & Monteleone, G. (2005) · Science · doi:10.1126/science.1106442 · Cited by 1,035
The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism
Kliewer, S. A., Goodwin, B., & Willson, T. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0038 · Cited by 921
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., & Berkenstam, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 872
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
Pharmacokinetic Interactions with Rifampicin: Clinical Relevance
Niemi, M., Backman, J. T., Fromm, M. F., Neuvonen, P. J., & Kivist??, K. T. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342090-00003 · Cited by 764
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Humanized xenobiotic response in mice expressing nuclear receptor SXR
Xie, W., Barwick, J. L., Downes, M., Blumberg, B., Simon, C. M., Nelson, M. C., Neuschwander-Tetri, B. A., Brunt, E. M., Guzelian, P. S., & Evans, R. M. (2000) · Nature · doi:10.1038/35019116 · Cited by 660
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Inflammation as a Tumor Promoter in Cancer Induction
Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640
Abdel-Razzak, Z., Loyer, P., Fautrel, A., Gautier, J. C., Corcos, L., Turlin, B., Beaune, P., & Guillouzo, A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13247-1 · Cited by 537
Regulation of Cytochromes P450 During Inflammation and Infection
Morgan, E. T. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709002246 · Cited by 488
Regulation of cytochrome p450 by inflammatory mediators: why and how?
Morgan, E. T. (2001) · PubMed · Cited by 408
Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR
Tabb, M. M., Sun, A., Zhou, C., Grün, F., Errandi, J., Romero, K., Pham, H., Inoue, S., Mallick, S., Lin, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303136200 · Cited by 387
Self-citationAssociation of celiac disease and intestinal lymphomas and other cancers
Catassi, C., Bearzi, I., & Holmes, G. K. T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.027 · Cited by 370
Langmann, T., Moehle, C., Mauerer, R., Scharl, M., Liebisch, G., Zahn, A., Stremmel, W., & Schmitz, G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.019 · Cited by 335
Albermann, N., Schmitz-Winnenthal, F. H., Z’graggen, K., Volk, C., Hoffmann, M. M., Haefeli, W. E., & Weiss, J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.06.018 · Cited by 270
Regulation of CYP3A4 Expression in Human Hepatocytes by Pharmaceuticals and Natural Products
Raucy, J. L. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.5.533 · Cited by 249
Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids
Almawi, W., & Melemedjian, O. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280069 · Cited by 242
Overview and pathogenesis of celiac disease
Kagnoff, M. F. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.008 · Cited by 228
Stedman, C. A. M., Liddle, C., Coulter, S. A., Sonoda, J., Alvarez, J. G. A., Moore, D. D., Evans, R. M., & Downes, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409794102 · Cited by 228
Geleziunas, R., Ferrell, S., Lin, X., Mu, Y., Cunningham, E. T., Grant, M., Connelly, M. A., Hambor, J. E., Marcu, K. B., & Greene, W. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5157 · Cited by 221
Grosset, J., & Leventis, S. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s440 · Cited by 218
Ke, S., Rabson, A. B., Germino, J. F., Gallo, M. A., & Tian, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106286200 · Cited by 209
Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00196-1 · Cited by 192
Faucette, S. R., Sueyoshi, T., Smith, C. M., Negishi, M., LeCluyse, E. L., & Wang, H. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098160 · Cited by 181
The Pregnane X Receptor Locus Is Associated With Susceptibility to Inflammatory Bowel Disease
Dring, M. M., Goulding, C. A., Trimble, V. I., Keegan, D., Ryan, A. W., Brophy, K. M., Smyth, C. M., Keeling, P. W. N., O’Donoghue, D., O’Sullivan, M., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.008 · Cited by 165
Miki, Y., Suzuki, T., Tazawa, C., Blumberg, B., & Sasano, H. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.12.005 · Cited by 145
Miki, Y., Suzuki, T., Kitada, K., Yabuki, N., Shibuya, R., Moriya, T., Ishida, T., Ohuchi, N., Blumberg, B., & Sasano, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1070 · Cited by 142
Maggio‐Price, L., Shows, D. M., Waggie, K. S., Burich, A., Zeng, W., Escobar, S. M., Morrissey, P., & Viney, J. L. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64894-8 · Cited by 141
Dotzlaw, H., Leygue, E., Watson, P. H., & Murphy, L. C. (1999) · PubMed · Cited by 140
Zhou, C., Tabb, M. M., Sadatrafiei, A., Grün, F., & Blumberg, B. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000299 · Cited by 123
Self-citationIdentification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance
Dussault, I., Yoo, H., Lin, M., Wang, E., Fan, M. Q., BATTA, A. K., Salen, G., Erickson, S. K., & FORMAN, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336235100 · Cited by 117
Calleja, C., Pascussi, J., Mani, J. C., Maurel, P., & Vilarem, M. (1998) · Nature Medicine · doi:10.1038/nm0198-092 · Cited by 117
TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
Riddick, D. S., Lee, C., Bhathena, A., Timsit, Y., Cheng, P., Morgan, E. T., Prough, R. A., Ripp, S. L., Miller, K. K. M., Jahan, A., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.4.367 · Cited by 114
Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites
Sonoda, J., Chong, L.-W., Downes, M., Barish, G. D., Coulter, S., Liddle, C., Lee, C., & Evans, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409481102 · Cited by 95
Understanding the chemotherapy of tuberculosis—current problems
MITCHISON, D. A. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.5.477 · Cited by 91
Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice†
Saini, S. P. S., Mu, Y., Gong, H., Toma, D., Uppal, H., Ren, S., Li, S., Poloyac, S. M., & Xie, W. (2005) · Hepatology · doi:10.1002/hep.20570 · Cited by 85
Coeliac Disease: Changing Views on Gluten-Sensitive Enteropathy
Wahab, P. J., Meijer, J. W. R., Goerres, M. S., & Mulder, C. J. J. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320621472 · Cited by 82
Phenytoin in cutaneous medicine: its uses, mechanisms and side effects.
Scheinfeld, N. S. (2003) · PubMed · Cited by 73
Immunomodulating Activity of Rifampicin
Ziglam, H. M., Daniels, I., & Finch, R. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.4.357 · Cited by 57
The Effects of RU 486 on Immune Function and Steroid-Induced Immunosuppressionin Vitro*
Voorhis, B. J. V., Anderson, D. J., & HILL, J. A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1195 · Cited by 56
Pharmaceutical use of mouse models humanized for the xenobiotic receptor
Xie, W., & Evans, R. M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02251-1 · Cited by 53
ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
Wolf, K., Wood, S. G., Hunt, J. A., Walton-Strong, B. W., Yasuda, K., Lan, L.-B., Duan, S. X., Hao, Q., Wrighton, S. A., Jeffery, E. H., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005256 · Cited by 42
The Use of Rifampin in the Treatment of Nontuberculous Infections: An Overview
Sande, M. A. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s399 · Cited by 40
Leite, R., Brown, A. G., & Strauss, J. F. (2004) · The FASEB Journal · doi:10.1096/fj.04-1684fje · Cited by 33
Some Plasma and Saliva Pharmacokinetics Parameters of Rifampicin in the Presence of Pefloxacin
Orisakwe, O. E., Akunyili, D., Agbasi, P. U., et al. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000117523.18923.4a · Cited by 12
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Venkatesh, M., Mukherjee, S., Wang, H., Li, H., Sun, K., Benechet, A. P., Qiu, Z., Maher, L., Redinbo, M. R., Phillips, R. S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.014 · Cited by 1,066
Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639
Self-citationZhang, L. S., & Davies, S. S. (2016) · Genome Medicine · doi:10.1186/s13073-016-0296-x · Cited by 500
Bile acid metabolism and signaling, the microbiota, and metabolic disease
Cai, J., Rimal, B., Jiang, C., Chiang, J. Y. L., & Patterson, A. D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108238 · Cited by 497
Metadata
- Authors
- Zhou, C.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-08-01
- Volume
- 116
- Issue
- 8
- Pages
- 2280-2289
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2132909109
- Cited by
- 402
- References
- 59
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.